![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessThe comparative mortality of an elite group in the long run of history: an observational analysis of politicians from 11 countries
This study aims to compare the mortality rate and life expectancy of politicians with those of the age and gender-matched general populations. This was an observational analysis of mortality rates of politicia...
-
Article
The Value of Genomic Testing: A Contingent Valuation Across Six Child- and Adult-Onset Genetic Conditions
The aim of this study was to elicit the willingness-to-pay (WTP) for genomic testing, using contingent valuation, among people with lived experience of genetic conditions in Australia.
-
Article
Open AccessIs There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries
Many high-income countries (HICs) have now vaccinated a substantial proportion of their population against COVID-19. Many low-income countries (LICs) may need to wait until at least 2022 before even the most v...
-
Article
Open AccessDevelopment of a life expectancy table for individuals with type 1 diabetes
Tables reporting life expectancies by common risk factors are available for individuals with type 2 diabetes; however, there is currently no published equivalent for individuals with type 1 diabetes. We aimed ...
-
Article
Public opinion on global rollout of COVID-19 vaccines
-
Article
Open AccessLessons from the pandemic on the value of research infrastructure
The COVID-19 pandemic has shed a spotlight on the resilience of healthcare systems, and their ability to cope efficiently and effectively with unexpected crises. If we are to learn one economic lesson from the...
-
Article
Open AccessHow Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton
-
Article
Open AccessGroup Testing for SARS-CoV-2: Forward to the Past?
-
Article
Open AccessCost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
A recent randomized trial showed that artemisinin–naphthoquine (AN) was non-inferior to artemether–lumefantrine (AL) for falciparum malaria and superior for vivax malaria in young Papua New Guinean children. T...
-
Article
Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes
The aim of this study was to develop a discrete-time simulation model for people with type 1 diabetes mellitus, to estimate and compare mean life expectancy and quality-adjusted life-years (QALYs) over a lifet...
-
Article
A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation
To review published studies on the effect of diabetes and its complications on utility scores to establish whether there is systematic variation across studies and to examine the implications for the estimatio...
-
Article
Open AccessChange in bias in self-reported body mass index in Australia between 1995 and 2008 and the evaluation of correction equations
Many studies have documented the bias in body mass index (BMI) determined from self-reported data on height and weight, but few have examined the change in bias over time.
-
Article
Estimating Utility Values for Health States of Overweight and Obese Individuals Using the SF-36
Objective: To use health-related quality-of-life (HRQoL) data from the Australian 1995 National Health Survey to estimate the impact of obesity (as measured by body mass index or BMI) on...